Akebia Therapeutics (AKBA) Reports Q4 Loss of $0.99

Akebia Therapeutics (NASDAQ: AKBA) reported Q4 EPS of ($0.99), versus ($0.66) reported last year.

For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Arrive AI and DXC Technology partner to bring delivery tech to factories
• Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained